CFA
BNTX icon

Carroll Financial Associates’s BioNTech BNTX Stock Holding History

Carroll Financial Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$42K Buy
165
+120
+267% +$32.9K ﹤0.01% 767
2021
Q3 		$12K Sell
45
-957
-96% -$304K ﹤0.01% 1136
2021
Q2 		$224K Buy
1,002
+957
+2,127% +$180K 0.01% 385
2021
Q1 		$4K Sell
45
-17
-27% -$1.8K ﹤0.01% 1392
2020
Q4 		$5K Buy
62
+17
+38% +$1.67K ﹤0.01% 1248
2020
Q3 		$3K Hold
45
– – ﹤0.01% 1260
2020
Q2 		$3K Hold
45
– – ﹤0.01% 1272
2020
Q1 		$2K Buy
+45
New +$1.75K ﹤0.01% 1280

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Carroll Financial Associates's BNTX Position: Q4 2021 in Review

Carroll Financial Associates increased its BioNTech (BNTX) stake by 267% in Q4 2021, buying an estimated $32.9K and bringing the position to 165 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Carroll Financial Associates first reported a position in BNTX in Q1 2020 and has held it in 8 quarters since. The position peaked at $224K in Q2 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • Carroll Financial Associates held 165 shares of BioNTech worth $42K as of Q4 2021.
  • Carroll Financial Associates bought 120 BioNTech shares in Q4 2021, an estimated $32.9K.
  • BioNTech made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #767 holding.
  • Carroll Financial Associates first reported a position in BioNTech in Q1 2020 and has held it in 8 quarters since.
  • Carroll Financial Associates's BioNTech position peaked at $224K in Q2 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.